After a record-setting 2025, medtech VC took a breather in Q1 2026, with deal value dipping 17.1% YoY on fewer outsized rounds. But the slowdown tells only half the story: VC exits roared back to life with $4.1 billion changing hands in just three months—nearly half of 2025’s full-year total—led by China-based EdgeMedical’s $2.2 billion surgical robotics IPO. Surgical devices and brain-computer interface (BCI) startups continued to dominate fundraising, while diagnostics and life sciences look to be bottoming after a prolonged drought, setting up a potential rebound in 2026. PE deal volume softened YoY, but sponsor-backed exit momentum is building, with 11 announced exits already on pace to outrun 2025’s full-year tally.
Read the full article: PitchBook Q1 2026 Medtech VC and PE Trends //
Source: https://pitchbook.com/news/reports/q1-2026-medtech-vc-and-pe-trends